Ferring Pharmaceuticals is a biopharmaceutical company dedicated to the development of innovative treatments in the areas of Gastroenterology, Reproductive Health, Urology, Endocrinology and Orthopaedics. Ferring headquarters operates from Saint-Prex, Switzerland and its products are available in 110 countries. http://www.ferring.com/en/about-ferring/ (link to Ferring Corporate video) In Australia, Ferring Pharmaceuticals markets PENTASA® (mesalazine) and CORTIMENT® (oral budesonide) indicated for the treatment of Inflammatory Bowel Disease (IBD), PICOSALAX® and the Fleet® range of products for bowel cleansing, and GLYPRESSIN® Solution (terlipressin) indicated for the treatment of bleeding oesophageal varices (BOV) and hepatorenal syndrome (HRS).
Ferring is a proud Gold Sponsor of GESA AGW 2016. Please visit us at stand 40.